An Underutilized Tool In The Treatment Of Resistant Depression And Anxiety
There is a well-known significant incidence of resistance to commonly used medication treatments for depression and anxiety. One underutilized, yet effective tool in addressing these disorders are monoamine oxidase inhibitors (MAOIs). Though considerable data and clinical experience over the last 60 years supports their value, that recent research demonstrates the exaggeration of safety and dietary concerns has hindered their use. This webinar will provide a primer on understanding and using these important and beneficial agents.
MAOIs: An Underutilized Tool In The Treatment Of Resistant Depression And Anxiety
November 19, 2023
Online
Accreditation Statement
Physicians
ACCME Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits TM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
https://nefesh.org/workshops/MAOI/view
FREE WEBINAR
MAOIs:
An Underutilized Tool In The Treatment Of Resistant Depression And Anxiety
Previously Recorded
Presenter: Shalom Feinberg, MD
Course Length: 1 Hour & 30 Minutes
Learning Objectives:
- Demonstrate a comprehensive understanding of the effectiveness and clinical significance of monoamine oxidase inhibitors in the field of psychiatric practice.
- Evaluate and discern the appropriate and safe utilization of these pharmaceutical agents within clinical contexts.
- Proficiently apply dosing strategies for monoamine oxidase inhibitors, demonstrating a nuanced comprehension of their administration in clinical settings.
This workshop Offers 1.5 Continuing Education Credits
This webinar is recorded and will not grant live credits.
There is a well-known significant incidence of resistance to commonly used medication treatments for depression and anxiety. One underutilized, yet effective tool in addressing these disorders are monoamine oxidase inhibitors (MAOIs). Though considerable data and clinical experience over the last 60 years supports their value, that recent research demonstrates the exaggeration of safety and dietary concerns has hindered their use. This webinar will provide a primer on understanding and using these important and beneficial agents.
MAOIs: An Underutilized Tool In The Treatment Of Resistant Depression And Anxiety
November 19, 2023
Online
Accreditation Statement
Physicians
ACCME Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits TM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Learning Objectives:
- Demonstrate a comprehensive understanding of the effectiveness and clinical significance of monoamine oxidase inhibitors in the field of psychiatric practice.
- Evaluate and discern the appropriate and safe utilization of these pharmaceutical agents within clinical contexts.
- Proficiently apply dosing strategies for monoamine oxidase inhibitors, demonstrating a nuanced comprehension of their administration in clinical settings.
Agenda:
- Introduction: why these medications are relevant (10 minutes)
- Basic pharmacology of MAOIs (20 Minutes)
- Addressing the concerns and fears around these medicines (20 Minutes)
- Clinical usage and dosing of MAOIs (30 Minutes)
- Concluding thoughts (10 Minutes)
This presentation is open to:
- Physicians
- Physician Assistance
- Nurses
- Social Workers
- Professional Counselors
- Therapists
- Psychologists
- Licensed Mental Health Practitioners
- Medical Doctors and Other Health Professionals
- Other professionals interacting with populations engaged in mental health based services
- New practitioners who wish to gain enhanced insight surrounding the topic
- Experienced practitioners who seek to increase and expand fundamental knowledge surrounding the subject matter
- Advanced practitioners seeking to review concepts and reinforce practice skills and/or access additional consultation
- Managers seeking to broaden micro and/or macro perspectives
Participants will receive their certificate electronically upon completion of the webinar and course evaluation form.
CE You!
Live Webinar:
MAOIs:
An Underutilized Tool In The Treatment Of Resistant Depression And Anxiety
November 19, 2023
Online
Accreditation Statement Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity / enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- In support of improving patient care, this activity has been planned and implemented by
Amedco LLC and CE You! Amedco LLC is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing
education for the healthcare team. Successful completion of this program qualifies for up
to 1.5 AMA PRA Category 1 Credit(s)TM.
Amedco LLC certifies that the attendee named above has participated in the enduring activity titled MAOIs:
An Underutilized Tool In The Treatment Of Resistant Depression And Anxiety, online, between September 10, 2021 and September 10, 2024 and is awarded the number of AMA PRA Category 1 CreditsTM listed above. National JA Provider # 4008163. - CE You! is an approved sponsor of the Maryland Board of Social Work Examiners for continuing education credits for licensed social workers in Maryland.
CE You! maintains responsibility for this program.